JLL Partners Buys BioClinica, JLL Partners

JLL Partners has acquired BioClinica, a provider of clinical trial management, and CoreLab Partners Inc., a provider of medical imaging and cardiac safety services. The firm will pay $7.25 a share for BioClinica, which results in an equity value of approximately $123 million. Specific terms of the CoreLab deal were not released.

DealsNorth AmericaUSBriefs